Skip to main content

Mirion Technologies, Inc.

corporate_fare Company Profile

Mirion Technologies, Inc.

MIR·NYSE·Industrial Applications And Services·CIK 0001809987

Mirion provides essential protection that enables the use of radiation to advance science, industry, and medicine. For over 60 years, Mirion and its predecessor companies have offered products, services, and software that allow customers to safely utilize ionizing radiation for applications benefiting health, safety, vitality, and technological progress. The company is a global leader in radiation safety and innovation, combining expertise with precise technologies. Mirion's operations are headquartered in Atlanta, Georgia, with additional operations in Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, Japan, and South Korea. Mirion operates through two reporting segments: Nuclear & Safety and Medical. The Nuclear & Safety segment supports advancements in nuclear energy and critical radiation safety, measurement, and analysis across nuclear power facilities, laboratories, research, and other industrial markets like defense. The Medical segment focuses on enhancing the quality and safety of cancer care delivery and supports applications in medical diagnostics and practitioner safety. Mirion's products, software, and services are sold directly and indirectly to a diverse range of customers. These include active nuclear power reactors, innovators in Small Modular Reactor (SMR) design, universities, numerous international government and supranational agencies, 23 of the 32 NATO militaries, national laboratories, environmental laboratories, research institutes, industrial companies, radiopharmaceutical drug manufacturers, hospitals, cancer centers, and small office healthcare providers.

Mirion Technologies, Inc. (NYSE:MIR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for MIR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-27, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for MIR spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Mirion Q3 Revenue Up 24.5% to $277.8M; 2026 Revenue and Cash Flow Guidance Raised
  • Mirion Posts 6.5% Organic Growth, Orders Surge 62%, Raises Q4 Outlook
  • Mirion Q2 Revenue Rises 20%, Reaffirms FY 2026 Guidance Despite Slight Miss
  • Mirion Technologies Reports Mixed Q1 2026 Results: Strong Revenue Growth Offset by Net Loss, Details Share Repurchase & CEO Option Grant
  • Mirion Technologies Reports Strong Q1 Revenue & Orders, Reaffirms Most 2026 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$925.4M
Net Income
$28.8M
Diluted EPS
$0.11
Op. Cash Flow
$143.3M
Free Cash Flow
$106.9M
Gross Profit
$438.6M
Operating Income
$51.5M
Cash & Equivalents
$412.3M
Total Debt
$444.7M
Debt / Equity
0.24×
Net Margin
3.1%
Shares Outstanding
229.96M sh
Source: 10-K · filed 2026-02-19 · accession 0001628280-26-009869

Short Interest & Short Volume

7.20 days to cover

FINRA reported short interest of 35,738,422 shares in MIR as of the October 30, 2026 settlement, a 13.2% decrease from the prior period — about 7.2 days to cover at its recent average daily volume. On November 19, 2026, 39.7% of MIR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)35,738,422 shares as of October 30, 2026
Change vs prior period▼ 13.2%
Days to cover7.20 at avg daily volume of 4,965,582
Daily short volume (FINRA facilities)39.7% of 802,600 shares on November 19, 2026
5-day average short volume50.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$16.1 -6.29% today
52-week range · as of 2026-10-27 $14.04 – $30.28
Market cap
$3.97B
Volume
3.5M (0.7× avg)
3-mo avg 4.7M
Live data · 2026-11-20 20:52 UTC · Market open

show_chartPrice Chart

Loading chart...

feed MIR - Latest Insights

MIR
Oct 27, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.16
Real-time Price: $16.10 info
Change: +$0.940 (+6%) info
Market Cap: $3.967B info
MIR
Oct 27, 2026, 4:15 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $15.41
Real-time Price: $16.10 info
Change: +$0.690 (+4%) info
Market Cap: $3.967B info
MIR
Jul 28, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $17.59
Real-time Price: $16.10 info
Change: -$1.49 (-8%) info
Market Cap: $3.967B info
MIR
Apr 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.66
Real-time Price: $16.10 info
Change: -$2.56 (-14%) info
Market Cap: $3.967B info
MIR
Apr 28, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.68
Real-time Price: $16.10 info
Change: -$2.58 (-14%) info
Market Cap: $3.967B info
MIR
Apr 13, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.26
Real-time Price: $16.10 info
Change: -$3.16 (-16%) info
Market Cap: $3.967B info
MIR
Feb 19, 2026, 5:06 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $21.47
Real-time Price: $16.10 info
Change: -$5.37 (-25%) info
Market Cap: $3.967B info
MIR
Feb 10, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.25
Real-time Price: $16.10 info
Change: -$5.15 (-24%) info
Market Cap: $3.967B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets